Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2000
06/14/2000EP1008649A2 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-b2(TGF-b2)
06/14/2000EP1007714A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
06/14/2000EP1007645A1 Human serum inducible kinase (snk)
06/14/2000EP1007631A1 Cardiac muscle regeneration using mesenchymal stem cells
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
06/14/2000EP1007556A2 Troponin subunits and fragments useful as angiogenesis inhibitors
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000EP1007545A2 Cyclopeptide derivatives as adhesion inhibitors
06/14/2000EP1007534A1 Bh3 interacting domain death agonist
06/14/2000EP1007524A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
06/14/2000EP1007514A1 Heterocyclic ketones as npy y5 antagonists
06/14/2000EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
06/14/2000EP1007096A1 Arginine silicate inositol complex and use thereof
06/14/2000EP1007085A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity
06/14/2000EP1007051A1 Integrin receptor antagonists
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007030A1 Solid pharmaceutical composition containing benzofurane derivatives
06/14/2000EP1007026A1 Integrin antagonists
06/14/2000EP1007025A1 Use of hydroxyguanidines
06/14/2000EP1006793A1 Anti-arrhythmic composition and methods of treatment
06/14/2000EP0823892B1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
06/14/2000CN1256629A Therapeutic compositions
06/14/2000CN1053451C Novel peptide compound with therapeutic active in blood coagulation reaction, its prep. and pharmaceutical composition thereof
06/14/2000CN1053378C Gingko seed and ginseng capsule
06/14/2000CN1053374C Chinese oral liquor for curing coronary heart disease and angina pectoris and its preparing method
06/13/2000US6075151 Inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related hyperlipidemia, cardiovascular disorders
06/13/2000US6075054 Antiarrhythmic pharmaceuticals having a cardioprotective component for infarct prophylaxis and infarct treatment as well as for the treatment of angina pectoris
06/13/2000US6075046 For the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous system which are associated with oxidative stress
06/13/2000US6075045 Method of treating paralysis of the extremities caused by cerebral infarction
06/13/2000US6075037 Endothelin receptor antagonists
06/13/2000US6075034 Spiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivatives
06/13/2000US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome
06/13/2000US6074873 Nucleic acids encoding NL-3
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000CA1341023C Peptide derivatives
06/09/2000WO2000020019A3 A composition for the prevention and/or treatment of atherosclerosis
06/08/2000WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000WO2000032627A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000WO2000032620A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032589A1 Eletriptan hydrobromide monohydrate
06/08/2000WO2000032587A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
06/08/2000WO2000032584A2 Nonsteroidal antiinflammatories
06/08/2000WO2000032582A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000032578A1 Benzimidazole compounds that are vitronectin receptor antagonists
06/08/2000WO2000032577A2 Substituted benzo[de]isoquinoline-1,3-diones
06/08/2000WO2000032570A1 Hydrazine derivatives
06/08/2000WO2000032556A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032555A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032267A2 Device for locally delivering a drug in a body cavity
06/08/2000WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032198A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion
06/08/2000WO2000032189A1 Celecoxib compositions
06/08/2000WO2000032174A2 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide
06/08/2000WO2000017228A3 Stereoselective process for enalapril
06/08/2000WO2000016760A3 New use of prostaglandin e2 antagonists
06/08/2000WO2000012481A3 Indazole derivatives with 5-ht2 receptor activity________________
06/08/2000CA2353602A1 Device for locally delivering a drug in a body cavity
06/08/2000CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000CA2353394A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
06/08/2000CA2353079A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000CA2352789A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion
06/08/2000CA2352760A1 Novel physiologically active substance, process for producing the same and utilization thereof
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/08/2000CA2352321A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/08/2000CA2352045A1 Substituted benzo[de]isoquinoline-1,3-diones
06/08/2000CA2351321A1 Hydrazine derivatives
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/07/2000EP1006115A2 Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005551A2 Tissue factor pathway inhibitor-3
06/07/2000EP1005545A1 Human extracellular matrix-1
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005449A1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same
06/07/2000EP1005377A2 Receptor-mediated gene delivery using bacteriophage vectors
06/07/2000EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY
06/07/2000EP1005360A1 Antioxidant protein 2, gene and methods of use therefor
06/07/2000EP1005347A1 Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
06/07/2000EP1005343A1 Use of csaid?tm compounds as inhibitors of angiogenesis
06/07/2000EP1005341A1 Il-8 receptor antagonists
06/07/2000EP1005334A1 Neuroprotective compounds and uses thereof
06/07/2000EP1005332A2 Pharmaceutical composition for reducing production of mcp-1 protein
06/07/2000EP0840606B1 Di- and trivalent small molecule selectin inhibitors
06/07/2000EP0806965A4 Cd44 expression in smooth muscle cells
06/07/2000CN1255854A Use of 1,2,4-triazolo [1,5-C] pyrimidine heterocyclic analogues for prepn. of medicaments useful for treatment of cerebrovascular disturbances
06/07/2000CN1255493A Novel dihydro and tetrahydro chinoline compounds, its prepn. method and medicinal compsns.
06/07/2000CN1255368A Chinese medicine for lowering blood pressure
06/07/2000CN1255365A Chinese medicine for lowering blood pressure
06/07/2000CN1053189C Pyridazino qujinoline compounds
06/07/2000CN1053187C Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
06/06/2000US6072068 Treating glucocorticoid-dependent diseases or symptoms
06/06/2000US6071968 Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
06/06/2000US6071953 For treating or preventing cardiovascular or gastrointestinal disorders, potassium channel modulators
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071938 Benzopyrans
1 ... 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 ... 1595